Dr. Hajer Almudaiheem is a distinguished pharmacy leader with extensive experience in drug policy, regulation, and clinical pharmacy practice. She serves as Advisor to the Assistant Deputy Minister for Therapeutic Supportive Services at the Ministry of Health (MoH) and as Director of the Drug Policy and Regulation Division in which had her fingure print in Healthcare Transformation and introducing value-based healthcare and established more than 15 registries 3 of which are on a national level. Dr. Almudaiheem graduated with a PharmD from King Saud University In 2015, she was appointed Head of the National Drug Information Center at the MoH, where she successfully established more than 50 centers across the Kingdom. She also led the operation of the MoH’s 937 hotline in 2014, expanding access to drug information services nationwide through a network of more than 60 drug information and clinical pharmacists. She is a Board Member of the Pharmacy Profession Society under the Saudi Commission for Health Specialties (SCFHS) and a Board Member of the Saudi Clinical Pharmacy Society (SSCP). Most recently, she was appointed Director of Governmental Affairs and Strategic Planning at NewBridge Pharmaceuticals.